Literature DB >> 23587318

An expanded cellular automata model for enantiomer separations using a β-cyclodextrin stationary phase.

Darren DeSoi1, Lemont B Kier, Chao-Kun Cheng, H Thomas Karnes.   

Abstract

Chromatographic scale enantiomer separation has not been modeled using cellular automata (CA). CA uses easy to adjust equations to different enantiomers under various chromatographic conditions. Previous work has demonstrated that CA modeling can accurately predict the strength of one-to-one binding interactions between enantiomers and β-cyclodextrin (CD) [1]. In this work, the model is expanded to a chromatographic scale grid environment in order to transform model output into HPLC chromatograms. The model accurately predicted the lack of chromatographic selectivity of mandelic enantiomers (1.05 published, 1.01 modeled) and the separation of brompheniramine enantiomers (1.13 published, 1.12 modeled) previously modeled in one-to-one interactions. By examining cyclohexylphenylglycolic acid (CHPGA) enantiomers, the model accurately predicted both the selectivity and resolution of the enantiomer peaks at varying chromatographic temperatures. Modeled changes in mobile phase pH agree with laboratory outcomes when examining peak resolution and selectivity. Changes in injection volume resulted in an increase in retention time of the modeled enantiomers as was observed in the published laboratory results.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587318     DOI: 10.1016/j.chroma.2013.03.060

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  1 in total

1.  Enantioseparation of mandelic acid derivatives by high performance liquid chromatography with substituted β-cyclodextrin as chiral mobile phase additive and evaluation of inclusion complex formation.

Authors:  Shengqiang Tong; Hu Zhang; Mangmang Shen; Yoichiro Ito; Jizhong Yan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-22       Impact factor: 3.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.